Follow The Filings

BTAIBioxcel Therapeutics Inc.

Q2 2026 13F holders among managers we track Latest ownership dossier

Ticker
BTAI
Type
Equity
Class
COMMON STOCK
Total reported value (long equity)
Manager Report date Value Shares